Weve rounded up the latest noteworthy health and well-being news, focusing on heart health, GLP-1 medications for type 2 diabetes and weight loss, and cholesterol
Along these lines, data from head-to-head trials comparing these therapies in patients with overweight or obesity had not yet been made available before the publication of the research by Truveta Research and the Providence Health System
Activation (weeks 12): begin at the documented once-daily 330 mcg dose to establish tolerance and observe fluid-balance and injection-site response before committing to a full cycle
There remains a need to explore alternative dosing schedules that could increase the convenience for patients while achieving comparable treatment targets to standard dosing recommendations
Less common but serious side effects include pancreatitis, gallbladder issues, and (in rare cases) thyroid tumors in patients with a personal or family history of medullary thyroid cancer or MEN-2
Its important to note, however, that GLP-1 therapy isnt a one-size-fits-all solution